🇺🇸 FDA
Pipeline program

recombinant interferon alfa

CDR0000065215

Phase 3 mab completed

Quick answer

recombinant interferon alfa for Melanoma (Skin) is a Phase 3 program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Melanoma (Skin)
Phase
Phase 3
Modality
mab
Status
completed

Clinical trials